Bulgaria Pharmaceuticals & Healthcare Q4 2020

Bulgaria Pharmaceuticals & Healthcare Q4 2020

Key View:

Bulgaria continues to make progress in the streamlining of its drugs supply chain and stabilising its pricing regimes. Atthe same time, the new proposals in the 2020 budget that aim to address issues with social security and healthcare funds reflectsthe current administration's ambition to address the long-term structural problems of Bulgaria's health system. Despite this,continued socioeconomic and industry-specific factors mean that opportunities for multinational pharmaceutical companiesremain limited.


Key View
Bulgaria Pharmaceuticals & Healthcare Covid-19 Impact
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Bulgaria Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Innovative Pharmaceuticals Risk/Reward Index
Bulgaria Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Sopharma
Bulgaria Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook